FDA Drug Application (202231) for LEVOTHYROXINE SODIUM by FRESENIUS KABI USA

Back to FDA Applications sponsored by FRESENIUS KABI USA

Application Number202231
Product Number001
FormPOWDER;INTRAVENOUS
Dosage100MCG/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NameLEVOTHYROXINE SODIUM
Active IngredientLEVOTHYROXINE SODIUM

Active IngredientCount
List of drugs with Active Ingredient LEVOTHYROXINE SODIUM9


Back to FDA Applications sponsored by FRESENIUS KABI USA